1. Home
  2. Publications
  3. Publications of type "Paper"

Publications of type "Paper"

Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.

    Drummond FJ, Kinnear H, O'Leary E, Donnelly, Gavin A, Sharp L.
    Journal of Cancer Survival. 2015. 9(2):361-372. PMID: 25563819

  2. Case mix does not fully explain variation in rates of non-surgical treatment of older women with operable breast cancer

    Morgan J, Richards P, Ward S, Francis M, Lawrence G, Collins K, Reed M, Wyld L
    European Journal of Surgical Oncology. 2015. 41(6): S18-S19 http://www.sciencedirect.com/science/article/pii/S0748798315001122

  3. Incidence and Survival of Gynecologic Sarcomas in England

    Francis M, Dennis NL, Hirschowitz L, Grimer R, Poole J, Lawrence G, Nordin A
    International Journal of Gynecological Cancer. 2015. 25(5): 850-857. PMID: 25853381

  4. Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010

    Hounsome LS, Verne J, McGrath JS, Gillatt DA
    European Urology. 2015. 67(6):1056-62 PMID: 25530608

  5. Comparison of melanoma incidence and trends among youth under 25 years in Australia and England, 1990-2010

    Wallingford SC, Iannacone MR, Youlden DR, Baade PD, Ives A, Verne J, Aitken JF, Green AC
    International Journal of Cancer. 2015. DOI: 10.1002/ijc.29598. [ePub ahead of print] PMID: 25960371

  6. Identifying Prognostic Indicators in Staging Metastatic Sarcomas Using Hospital Episode Statistics.

    Francis M, Dennis N, Charman J, Lawrence G.
    Cancer Investigation. 2015. doi:10.3109/07357907.2015.1019675. [ePub online ahead of print] PMID: 25919082

  7. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2).

    4. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Silva GAE, Chen W, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP, the CONCORD Working Group.
    The Lancet. 2015. 385(9972):977-1010. PMID: 25467588

  8. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality-of-life in prostate cancer survivors: a curate's egg.

    O'Leary, E, Drummond FJ, Gavin A, Kinnear H and Sharp L
    Quality of Life Research. 2015. DOI: 10.1007/s11136-015-0958-y [ePub ahead of print]. PMID: 25791618

  9. Assessing the impact of an English national initiative for early cancer diagnosis in primary care

    Rubin G, Gildea C, Wild S, Shelton J, Ablett-Spence I
    British Journal of Cancer. 2015. 112:S57–S64 PMID: 25734381

  10. Risk of oesophageal cancer among patients previously hospitalised with eating disorder

    Brewster DH, Nowell SL, Clark DN.
    Cancer Epidemiol 2015 Mar 10. pii: S1877-7821(15)00045-4. doi: 10.1016/j.canep.2015.02.009. [Epub ahead of print]

  11. Effect of longer health service provider delays on stage at diagnosis and mortality in symptomatic breast cancer

    Murchie P, Raja EA, Lee AJ, Brewster DH, Campbell NC, Gray NM, Ritchie LD, Robertson R, Samuel L
    Breast 2015 Mar 6. pii: S0960-9776(15)00042-9. doi: 10.1016/j.breast.2015.02.027. [Epub ahead of print]

  12. Gleason drift in the NIHR ProtecT study

    Oxley J, Simpkin A, Goepel J, Varma M, Griffiths D, Grigor K, Mayer N, Warren A, Deshmukh N, Bhattarai S, Dormer J, Hounsome L, Adamczyk LA, Metcalfe C, Lane JA, Davis M, Donovan JL, Neal DE, Hamdy FC, Robinson MC; ProtecT Study Group.
    Histopathology. 2015. 66(3):438-46 PMID: 25231130

  13. Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.

    1. Bhat SK, McManus DT, Coleman HG, Johnston BT, Cardwell CR, McMenamin U, Bannon F, Hicks B, Kennedy G, Gavin AT, Murray LJ.
    Gut. 2015. 64(1):20-25. PMID: 24700439

  14. Patient reported “ever had” and “current” long term physical symptoms following prostate cancer treatments.

    6. Gavin AT, Drummond FJ, Donnelly C, O’Leary E, Sharp L, Kinnear HR
    British Journal of Urology International. 2015. DOI: 10.1111/bju.13036 [ePub ahead of print] PMID: 25597493

  15. An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom

    Ironmonger L, Ohuma E, Ormiston-Smith N , Gildea C, Thomson CS, Peake MD
    British Journal of Cancer. 2015. 112: 207-216 PMID: 25461805

  16. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.

    Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V, the RARECARE Working Group.
    Cancer Epidemiol 2014; 38: 670-8.

  17. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer

    Libby G, Brewster DH, Steele RJ
    Br J Surg 2014; 101: 1607-15.

  18. Funnel plots for population-based cancer survival: principles, methods and applications

    Quaresma M, Coleman MR, Rache B (2014)
    Statistics in Medicine, 33: 1070–1080. PMID: 24038332

  19. Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival

    Murchie P, Raja EA, Brewster DH, Campbell NC, Ritchie LD, Robertson R, Samuel L, Gray N, Lee AJ
    Br J Cancer 2014 Jul 3. doi: 10.1038/bjc.2014.352. [Epub ahead of print] PMID: 24992583

  20. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010

    Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA
    Cancer Epidemiol 2014; 38: 227-34 PMID: 24726751